Early medication discontinuation on long-term recovery outcome in first-episode psychosis

JAMA Psychiatry

Volumn 71, Issue 2, 2014, Pages 206-207

  Undurraga, Juan ^a   Murru, Andrea ^a   Vieta, Eduard ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

DRUG WITHDRAWAL; FUNCTIONAL ASSESSMENT; FUNCTIONAL STATUS; HUMAN; LETTER; LONG TERM SURVIVAL; OUTCOME ASSESSMENT; PSYCHOSIS; SCHIZOPHRENIA;

ANTIPSYCHOTIC AGENTS; FEMALE; HUMANS; MALE; PSYCHOTIC DISORDERS;

EID: 84893873037     PISSN: 2168622X     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapsychiatry.2013.2993     Document Type: Letter

References (5)

1. Wunderink L, Nieboer RM, Wiersma D, Sytema S, Nienhuis FJ. Recovery in remitted first-episode psychosis at 7 years of follow-up of an early dose reduction/discontinuation or maintenance treatment strategy: long-term follow-up of a 2-year randomized clinical trial. JAMA Psychiatry. 2013;70(9):913-920.
2. National Collaborating Centre for Mental Health (UK). Schizophrenia: Core Interventions in the Treatment and Management of Schizophrenia in Adults in Primary and Secondary Care (Update). London, England: National Institute for Health and Clinical Excellence; 2009.
3. Wunderink L, Nienhuis FJ, Sytema S, Slooff CJ, Knegtering R, Wiersma D. Guided discontinuation versus maintenance treatment in remitted first-episode psychosis: relapse rates and functional outcome. J Clin Psychiatry. 2007;68(5):654-661.
4. Psaty BM, Prentice RL. Minimizing bias in randomized trials: the importance of blinding. JAMA. 2010;304(7):793-794.
5. Schützwohl M, Jarosz-Nowak J, Briscoe J, Szajowski K, Kallert T; Eden Study Group. Inter-rater reliability of the Brief Psychiatric Rating Scale and the Groningen Social Disabilities Schedule in a European multi-site randomized controlled trial on the effectiveness of acute psychiatric day hospitals. Int J Methods Psychiatr Res. 2003;12(4):197-207.